ArticleArchives of public health = Archives belges de sante publique2026
SPEACx: a screening pathway-based evaluation and audit framework of cervical cancer diagnostic routes in a population-based programme.
Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer audits are widely used to evaluate organized screening programmes, yet existing approaches often fail to clearly attribute cancer diagnoses to specific stages of the screening pathway. This limits the ability to translate audit findings into actionable public health improvements. We developed the Screening Pathway-based Evaluation and Audit of Cervical Cancer (SPEACx) framework to attribute cervical cancer diagnoses across the screening pathway and improve programme evaluation.
methodsThe SPEACx framework was developed through an iterative expert consensus process involving screening programme coordinators, gynecologists, and epidemiologists. Cancer cases are attributed to operational stages of screening, including invitation, participation, test performance, follow-up, and post-treatment surveillance. As an applied example, all cervical cancer cases diagnosed within the population-based screening programme of the Basque Country (Spain) between 2018 and 2024 were analysed. Diagnostic pathways and FIGO stage were determined through clinical record review, and stage distributions were compared across major diagnostic pathways.
resultsAmong 678 confirmed cervical cancer cases, 34.8% were diagnosed through the screening programme in asymptomatic women, 6.1% were interval cancers, and 55.9% were diagnosed outside the organized programme. Programme-detected cancers were predominantly diagnosed at early stages, whereas interval cancers and cancers diagnosed outside the programme showed substantially higher proportions of advanced disease. Aggregation of SPEACx categories into operational domains enabled identification of key system vulnerabilities related to participation gaps, eligibility criteria, test performance, and follow-up pathways, supporting the development of targeted quality improvement interventions.
conclusionsSPEACx provides a structured and adaptable framework for attributing cervical cancer diagnoses to specific stages of screening delivery. By enabling attribution of cancer diagnoses to screening processes, SPEACx supports targeted quality improvement and provides a practical tool for public health evaluation of organized cervical cancer screening programmes.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.